When something could save lives, having an abundance of it on hand is a good thing. On the other hand, if there’s a scarcity of it, it won’t be readily available when it’s needed—and many lives will be put at risk. This is true for a prostate cancer (PCa) imaging agent called Gallium-68 (68Ga or keep reading

Everyone who wants to go through a prostate biopsy, raise your hand. What, no takers? Not surprising. Conventional transrectal ultrasound (TRUS) biopsies commonly involve 12-14 needles, and sometimes as many as 24 in a “saturation” biopsy. TRUS biopsies frequently involve pain and risk of infection. There can be side effects like bleeding and even erectile keep reading

The Radiological Society of North America (RSNA) was founded in 1915. It now has over 54,000 members. There are not only radiologists, but also other medical professionals and even medical physicists. At its annual gathering, its huge attendance makes it one of the largest medical conferences in the world... keep reading

Patients who choose robotic-assisted radical prostatectomy (RARP) believe it’s the best way to eradicate prostate cancer (PCa). In their mind, this equates to a cure. In fact, PCa can recur (come back) as long as 15 or more years after any whole-gland treatment. Increasingly, no one talks about “cure” anymore. Instead, “success” is defined as keep reading

No one wants to go through an invasive clinical procedure if they don’t need it. Who wouldn’t prefer to be spared from simple invasions like blood draws or enemas, let alone major surgeries like replacing a heart valve or removing a lung? From the viewpoint of an individual, we’d like to avoid these if we keep reading

Contrary to popular belief, a new study says you’re never too old to get high-risk prostate cancer (PCa). There’s been a recent trend to cut back on PSA screening for men over age 70. It wasn’t that long ago when such organizations as the American Urological Society and the American Society of Clinical Oncology promoted keep reading

Do you ever regret a decision that turns out to have a bad outcome? This is the situation for many prostate cancer (PCa) patients who chose radical prostatectomy (RP). A 2017 study found that 15% of PCa patients regret their treatment choice, with twice as many patients ruing the day they opted for RP or keep reading

I am frequently asked by patients how Focal Laser Ablation (FLA) compares to Radical Prostatectomy (RP) in terms of cancer control. After all, many of the men with localized prostate cancer (PCa) who come to Sperling Prostate Center have already been told by a urologist that they qualify for a nerve-sparing robotic RP that will keep reading

The term artificial intelligence or AI is at once exciting, mysterious, and even a little scary. As each of us goes through our day, we probably have no idea how much of our activities are touched by AI. Examples include your smartphone calculating the speed of your commute to work, the spam filter in your email, and online shopping recommendations that pop up when you buy a particular nutritional supplement on Amazon. keep reading

The tug-of-war continues between prostate cancer patients who want to be treated with proton beam therapy (PBT) vs. their insurance companies. As you can read from the blog below, payers are denying PCa coverage due to the high cost of the treatment coupled with lack of evidence showing superiority over conventional radiation therapies... keep reading